Palvella Therapeutics, Inc. (PVLA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-04) · 99.1 · 99.2 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-31) · 99.1 · 99.2 | 8-K (2026-02-24) | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 · 99.2 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 · 99.2 | ||
| 10-K | FY-2024 | 8-K (2025-03-31) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | — | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-03-27) · 99.1 | ||
| 10-Q | Q3-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Operations and Comprehensive (loss) Income | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Changes In Preferred Stock and Stockholders' Equity (deficit) (unaudited) | — |
|
| Condensed Consolidated Statements of Changes In Preferred Stock, Convertible Preferred Stock and Stockholders' Equity (deficit) (unaudited) | — |
|
| Consolidated Statements of Changes In Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | ||
| Condensed Consolidated Statements of Changes In Preferred Stock and Stockholders' Equity (deficit) (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Commitments and Contingencies | ||
| Convertible Notes Payable | — |
|
| Convertible Preferred Stock | — |
|
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Description of Business, Organization and Liquidity | ||
| Equity Incentive Plans | ||
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net (loss) Income Per Share | — |
|
| Note 1 | ||
| Note 10 | ||
| Note 11 | ||
| Note 12 | — |
|
| Note 13 | — |
|
| Note 2 | ||
| Note 3 | ||
| Note 4 | ||
| Note 5 | ||
| Note 6 | ||
| Note 7 | ||
| Note 8 | ||
| Note 9 | ||
| Operating Lease Commitments | — |
|
| Pay Vs Performance Disclosure | ||
| Reverse Merger | ||
| Segment Information | ||
| Stockholders' Equity | ||
| Strategic Agreements | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||